Xiamen Amoytop Biotech (SHA:688278) adjusted the proposed investment amounts for its convertible bond fundraising projects, following a net proceeds shortfall.
Net proceeds came to 1.52 billion yuan, lower than the planned 1.53 billion yuan, according to a Wednesday filing with the Shanghai bourse.
The adjustments affect the Biotech innovation integration center project, which saw its allocation reduced to 446.2 million yuan from 461.9 million yuan.
Shares of the drugmaker were up 7% Wednesday.
Huadian New Energy (SHA:600930) will issue two tranches of 250-day bonds worth a total of 3 billion yuan, according to a Wednesday filing with the Shanghai bourse.The first tranche is worth 2 billion yuan with an interest rate of 1.41%, with Bank of China as bookkeeping manager and lead underwriter, and China Minsheng Bank and China Merchants Bank as joint lead underwriters.The second tranche is worth 1 billion yuan and is underwritten by Industrial Bank and Agricultural Bank of China.Both issuances mature on April 24, 2027.Shares fell 2% during morning trading on Wednesday.
Huaneng Lancang River Hydropower (SHA:600025) raised 3 billion yuan via the issue of two tranches of ultra-short-term commercial papers to repay interest-bearing liabilities.The issue of 100-day papers carrying a coupon rate of 1.40% raised 2 billion yuan, while the issue of 109-day papers at 1.41% raised 1 billion yuan, according to a Wednesday filing with the Shanghai bourse.Bank of China serves as lead underwriter, with Industrial and Commercial Bank of China and China Construction Bank as joint lead underwriters.Shares of the hydropower company were up 1% in recent trade.
Guotai Junan Securities (SHA:601211, HKG:2611) indirect unit Guotai Junan Holdings issued 500 million yuan in medium-term notes under its $5.5 billion medium-term note program.Proceeds will be used to refinance maturing debt and boost working capital, according to a Tuesday aftermarket filing.